Our company has entered into a special agreement with the University of Tokyo.
As reported in our previous press release, the Institute for Quantitative Biosciences at the University of Tokyo (hereinafter referred to as “IQB”) and our company have jointly developed, implemented, and advanced unique security equipment known as the “IQB Gate.” This initiative has been featured in the “IQB Handbook,” a publication issued by IQB.
In addition to the digital transformation of the institute facilitated by the “IQB Gate,” our product “FLD-A1c®” is also being utilized to enhance the welfare benefits of the members of the institute.
Moving forward, we will continue to collaborate with top-tier research institutions in our endeavor to deepen our proprietary cutting-edge technologies.